Abstract
The present study reports the results of intravenous cyclosporine in 32 patients with refractory and/or severe attacks of ulcerative colitis (UC). Twenty of 32 patients responded to intravenous cyclosporine; cyclosporine was clinically effective and improved colonic lesions. However, one colonic perforation and one postoperative death were observed in two patients with severe endoscopic colitis who had failed to reach clinical remission with high-dose corticosteroids and cyclosporine. Moreover, after a median follow-up of 190 days, only one-third of the patients avoided colectomy. No predictive factor of response to cyclosporine was identified. This study confirms that cyclosporine is effective in severe UC but suggests that its use could be associated with serious complications in patients with severe lesions who had failed to settle with corticosteroids and cyclosporine.
Similar content being viewed by others
References
Edwards FC, Truelove SC: The course and prognosis of ulcerative colitis. Short term prognosis. Gut 4:299–308, 1963
Goligher JC, Hoffman DC, De Dombal FT: Surgical treatment of severe attacks of ulcerative colitis with special reference to the advantage of early operation. Br Med J 9:389–407, 1970
Truelove SC, Jewell DP: Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1:1067–1070, 1974
Truelove SC, Willoughby CP, Lee EG, Kettlewell MAGW: Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 2:1087–1088, 1978
Carbonnel F, Lavergne A, Lémann M, Bitoun A, Valleur P, Hautefeuille P, Galian A, Modigliani R, Rambaud JC: Colonoscopy of acute colitis. A safe and reliable tool for the assessment of severity. Dig Dis Sci 39:1550–1557, 1994
Lichtiger S, Present D, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S: Cyclosporin in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 330:1841–1845, 1994
Fazio VW: Toxic megacolon in ulcerative colitis and Crohn's colitis. Clin Gastroenterol 9:389–407, 1980
Kaplan E, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958
Sandborn WJ: A critical review of cyclosporine therapy in inflamatory bowel disease. Infl Bowel Dis 1:48–63, 1995
Actis GC, Otobrelli A, Pera A, Barletti C, Ponti V, Pinna-Pintor M, Verme G: Continuously infused cyclosporine at low dose is sufficient to avoid colectomy in acute attacks of ulcerative colitis without the need for high-dose steroids. J Clin Gastroenterol 17:10–13, 1993
Baert F, Hanauer SB: Cya in severe steroid-resistant UC: Long term results of therapy. Gastroenterology 106:A648, 1994
Sandborn WJ: A critical review of cyclosporine therapy in inflammatory bowel disease. Infl Bowel Dis 1:48–63, 1995
McIntyre PB, Powell-Tuck J, Wood SR, Lennard-Jones JE, Lerebours E, Hecketsweiler P, Galmiche JP, Colin R: Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 27:481–485, 1986
Dickinson RJ, Ashton M, Axon ATR, Smith RC, Yeung CK, Hill GL: Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 79:1199–1204, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carbonnel, F., Boruchowicz, A., Duclos, B. et al. Intravenous cyclosporine in attacks of ulcerative colitis. Digest Dis Sci 41, 2471–2476 (1996). https://doi.org/10.1007/BF02100145
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02100145